Oracle Corp. Acquires Phase Forward for $685,000,000

  • Feed Type
  • Date
  • Company Name
    Phase Forward
  • Mailing Address
    880 Winter Street Waltham, MA 02451
  • Company Description
    Phase Forward (Nasdaq: PFWD) is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm(TM)), clinical data management (Clintrial(TM)), clinical trials signal detection (CTSD(TM)), strategic pharmacovigilance (WebVDME(TM) and Signal Management), adverse event reporting (Clintrace(TM)) and applied data standards (WebSDM(TM)). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Phase Forward Inc. says it has agreed to be acquired by Oracle Corp. for $685 million in cash.

Trending on Xconomy